PINHONBIO® Hydroxyectoine 99%: the evaluation brief

A focused ingredient brief

Hydroxyectoine deserves its own evaluation record rather than being treated as another name for ectoine. This brief starts with the published identity of PINHONBIO® Hydroxyectoine (PH-SynBio 008) and builds a practical screening plan around it. It is an ingredient evaluation brief, not an announcement of a newly verified launch date.

The development question

The useful question is specific: what should this ingredient contribute to your intended formula, and what evidence would demonstrate that contribution? Define the target product, audience and measurable endpoint before choosing a test matrix. The presence of an ingredient in a formula is not, by itself, evidence for a finished-product claim.

The identity at a glance

The following fields summarize the currently published supplier identity. Purchase acceptance should use the applicable specification and batch documents.

Turn the grade into a study plan

Treat the analytical grade as an input to material qualification. Prepare a control base and an ingredient-containing version under comparable conditions. Keep changes to the base, process and packaging documented so that a later difference can be interpreted. Decide in advance which physical, analytical and user-relevant observations matter to the project.

Application opportunities to evaluate

A serum, cream or eye-care concept can each require a different study design. Choose the format from the development brief rather than assuming the same incorporation approach will work across all three. A sensitive-skin positioning also requires a tolerability assessment of the complete product.

Technical considerations

Use a product-specific technical document to establish incorporation conditions before a trial. A raw-material QC pH range must not be repurposed as a recommended finished-formula pH range. Record dissolution, appearance, precipitation and active-content observations under your intended stability program.

This brief does not prescribe a use level, processing temperature or formula pH. Those values require current product-specific evidence and validation in the complete formulation.

Sources & scope

• PINHONBIO® Hydroxyectoine: product identity and grade

Supplier material reviewed October 1, 2026. General evaluation recommendations are editorial perspectives, not reported PINHONBIO test results.

Related reading